AMNEAL PHARMACEUTICALS, INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $2.09B | $152.7M | $13.2M |
| FY2022 | $2.21B | $-94.9M | $-270.6M |
| FY2023 | $2.39B | $204.4M | $-84.0M |
| FY2024 | $2.79B | $249.3M | $-116.9M |
| FY2025 | $3.02B | $394.1M | $72.1M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $2.09B | $152.7M | $13.2M |
| FY2022 | $2.21B | $-94.9M | $-270.6M |
| FY2023 | $2.39B | $204.4M | $-84.0M |
| FY2024 | $2.79B | $249.3M | $-116.9M |
| FY2025 | $3.02B | $394.1M | $72.1M |